⌘K

Login Start Free

Home/Filings/4/0001213900-24-020087

4//SEC Filing

HSU ERIC C 4

Accession 0001213900-24-020087

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 3:20 PM ET

Size

5.5 KB

Accession

0001213900-24-020087

Insider Transaction Report

Form 4

Period: 2024-03-04

InMed Pharmaceuticals Inc.INM

Sr VP, Pre-Clinical Res/Dev

Transactions

Expiration (Short)
Employee Stock Option (Expiration)
2024-03-04−309→ 52,545 total
Exercise: $364.72From: 2019-03-04Exp: 2024-03-04→ Common shares (309 underlying)

Footnotes (1)

[F1]Converted from the Canadian dollar exercise price of C$495 using an exchange rate of C$1.3572 = $US1.00

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001817867

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 3:20 PM ET
Size: 5.5 KB

View on SEC.gov